Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii for prevention of antibiotic-associated diarrhoea in older inpatients
2008-001426-14Phase 4Completed
- Sponsor
- ASST Lecco
- Start
- May 2009
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of saccharomyces boulardii in antibiotic-associated diarrhea (AAD), Clostridioides difficile colitis (CDI) and bacterial disease, sponsored by ASST Lecco. Primary endpoint: Incidence of diarrhoea. Started May 2009; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
antibiotic-associated diarrhea (AAD)Clostridioides difficile colitis (CDI)bacterial disease
Beyond the preview
Go deeper on 2008-001426-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001426-14.